Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Aortic stenosis is a common condition associated with major morbidity, mortality, and health-care costs. Nevertheless, we currently lack any effective medical therapies that can treat or prevent disease development or progression. Modern advances in echocardiography and CT have helped improve the assessment of aortic stenosis severity and monitoring of disease progression, whereas cardiac MRI informs on myocardial health and the development of fibrosis. In a series of recent studies, 18F-NaF PET/CT has been shown to assess valvular disease activity and progression, providing mechanistic insights that can inform potential novel therapeutic approaches. This review will examine the latest advances in the imaging of aortic stenosis and bioprosthetic valve degeneration and explore how these techniques can assist patient management and potentially accelerate novel therapeutic developments.

Original publication

DOI

10.2967/jnumed.121.262304

Type

Journal article

Journal

J nucl med

Publication Date

03/2022

Volume

63

Pages

353 - 358

Keywords

18F-sodium fluoride PET/CT, CT calcium scoring, CT-AVC, aortic stenosis, coronary CT angiography, microcalcification, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Humans, Multimodal Imaging, Positron Emission Tomography Computed Tomography